Abstract: Disclosed are methods and compositions for improving metal extraction processes by introducing at least one cationically charged compound selected from a group consisting of amines, particularly quaternary amines such as alkyldimethylbenzylammonium chlorides (ADBAC compounds), polyamines and other suitable cationic organic materials, and mixtures thereof, for neutralizing and/or coagulating excess anionic organic compounds including, for example, flotation reagents, surfactants, polymers, flotation reagent by-products and/or anti-scalant additives found in metal concentrate streams, and thereby reduce the downstream fouling of the activated carbon by these compounds.

Abstract: A process for treating spent catalyst containing heavy metals, e.g., Group VIB metals and Group VIII metals is provided. In one embodiment after deoiling, the spent catalyst is treated with an ammonia leach solution under conditions sufficient to dissolve the group VIB metal and the Group VIII metal into the leaching solution, forming a leach slurry. After solid-liquid separation to recover a leach solution, chemical precipitation and solids repulping is carried out to obtain an effluent stream containing ammonium sulfate (Amsul), ammonium sulfamate, Group VB, Group VIB and Group VIII metals. Following sulfidation, the Group VIII metal is fully removed and Group VB and Group VI metals are partially removed from the Amsul stream.

Abstract: A hydrogen chloride removal process includes (i) contacting in a reactor an aqueous solution, which includes one or more Fe2+-compounds, with a fluid, which includes an oxidizing agent, hydrochloric acid gas and optionally chlorine gas; and (ii) oxidizing the Fe2+-compounds to Fe3+-compounds, thereby converting the fluid to an exhaust gas, which has a reduced hydrochloric acid content.

Abstract: Provided is a method for producing cobalt sulfate, wherein, on the occasion of separating an acidic solution containing calcium, magnesium and sodium as impurities from a cobalt chloride solution by solvent extraction, when a diluent is added to the extractant to be used to dilute the extractant by 10% to 30% by volume; in Step 1, the operational pH is maintained in the range of 4.0 to 5.0 and the liquid volume ratio of organic phase/liquid phase is maintained in the range of 5.0 to 7.0; in Step 2, the operational pH is maintained in the range of 4.0 to 4.5 and the liquid volume ratio of organic phase/liquid phase is maintained in the range of 5.0 to 10.0; and in Step 3, the pH is maintained in the range of 0.5 to 1.0.

Abstract: It is an object to provide a method for producing magnesium oxide by which magnesium oxide being high in purity and low in impurity content can be produced simply and efficiently from a sulfuric acid solution containing magnesium and calcium such as waste water. In the present invention, calcium is precipitated as calcium sulfate and separated by concentrating a sulfuric acid solution containing magnesium and calcium, and magnesium is precipitated as magnesium sulfate and separated by further concentrating the solution resulting from the separation of calcium. The separated magnesium sulfate is roasted together with a reductant, so that magnesium oxide and sulfur dioxide are obtained. The resulting magnesium oxide is washed to produce magnesium oxide with high purity.

Abstract: A method oxidizes ferrous iron to ferric iron. The method includes providing a liquid, which includes the ferrous iron, and a gas, which includes an oxidizing agent, such as oxygen and/or chlorine; providing two separate mixes, with both mixes including the gas and the liquid; and colliding the separate mixes, thereby obtaining the ferric iron.

Abstract: A method of extracting lithium from a lithium bearing solution and specifically, economically extracting lithium from a lithium bearing solution comprising the steps of: adding a nucleus particle to a lithium bearing solution; and precipitating the dissolved lithium in the lithium bearing solution as lithium phosphate by adding a phosphorous supplying material to the lithium bearing solution including the nucleus particle is provided.

Abstract: Process for treating a medium by the removal or destruction of one or more undesired substances present in said medium, comprising combining hydrogen peroxide and alkali hydroxide in an aqueous solution to form superoxide, and bringing the resultant superoxide-containing solution into contact with said medium. The process is useful for the destruction of halogenated organic pollutants and also for carbon dioxide removal from flue gases. The process can also be applied for soil remediation.

Abstract: The present invention discloses an adsorbent material having the following formula: CuwZnFeyAlz(OH)2(A)(y+z)/2.mH2O, wherein w+x+y+z=1; and 0.20?w?0.60; 0.20?x?0.60; 0.05?y?0.25; 0.05?z?0.25; 0.20?(y+z)?0.33; and 0.50?m?0.80; a process for producing the adsorbent material and its use for removing sulfur-containing matter from gaseous streams.

Abstract: A method for producing a usable by-product in a cyclone reactor. The method comprises introducing a reactant into a housing of the reactor through an inlet; using a burner to combust a first portion of the reactant in an exothermic reaction provided in a flame zone near a center of the housing; consuming a second portion of the reactant in an endothermic reaction near an outer wall of the housing to produce the by-product as part of a slag layer; and removing the slag layer including the by-product though an outlet in the housing; wherein the endothermic reaction takes place at a temperature of at least 1600° C.

Abstract: A process for preparing sodium bicarbonate particles, comprising the steps of: (a) adding at least one alkali metal carbonate to an aqueous solution in order to form an aqueous composition; wherein the alkali metal carbonate comprises sodium carbonate and wherein the aqueous composition comprises at least one polycarboxylic acid and/or the salts thereof, in an amount of at least 200 ppm based on the weight of the aqueous composition; and (b) precipitating solid particles comprising sodium bicarbonate crystals and separating said sodium bicarbonate particles from the aqueous composition, in order to obtain sodium bicarbonate particles and an aqueous mother liquor.

Abstract: Systems and a method for forming carbon nanotubes are described. A method includes forming carbon nanotubes in a reactor, using a Bosch reaction. The carbon nanotubes are separated from a reactor effluent to form a waste gas stream. The feed gas, a dry waste gas stream, or both, are heated with waste heat from the waste gas stream. The waste gas stream is chilled in an ambient temperature heat exchanger to condense water vapor, forming a dry waste gas stream.

Abstract: A device for mixing and cooling two reactive liquids, comprising a bundle type heat exchanger with parallel tubes, a head space open to one end of all tubes, a first inlet to the head space for introducing a first liquid and a second inlet to the head space with a multitude of nozzles for introducing a second liquid, the nozzles being located within the head space and oriented to direct the introduced liquid transverse to the axis of the tubes of the tube bundle, is useful for making peroxomonosulphuric acid from 85 to 98% by weight sulphuric acid introduced into the first inlet of the device and 50 to 80% by weight aqueous hydrogen peroxide introduced into the second inlet of the device.

Abstract: The invention relates to a process and apparatus for recovering sulfur (9). In a sour gas scrubbing apparatus (S) comprises a scrubbing part (SP) and a regeneration part (RP), wherein sulfur components and carbon dioxide are selectively removed from a crude synthesis gas (2) with the aid of a circulating scrubbing agent (3). A sulfur-containing gas fraction (8) produced during the regeneration of loaded scrubbing agent is supplied to a sulfur recovery system (SR) in which an off-gas (10) comprising carbon dioxide and also sulfur components is formed. The off-gas is hydrogenated (H) and subsequently subjected to a gas scrubbing operation (Z). The hydrogenated off-gas (12) is scrubbed, independently of the crude synthesis gas (2), and scrubbing agent (13) removed from the scrubbing agent circuit of the sour gas scrubbing apparatus (S) is used to scrub out sulfur components from the hydrogenated off-gas (12).

Abstract: The present invention discloses a method for thermochemical production of hydrogen and oxygen from water by a low temperature, multi-step, closed, cyclic copper-chlorine (Cu—Cl) process involving the reactions of copper and chlorine compounds. A method for production of hydrogen via Cu—Cl thermochemical cycle consists of four thermal reactions and one electrochemical reaction and one unit operation. The cycle involves six steps: (1) hydrogen production step; (2) copper production step; (3) drying step; (4) hydrogen chloride production step; (5) decomposition step; (6) oxygen production step. The net reaction of the sequential process is the decomposition of water into hydrogen and oxygen. The methods for production of copper oxide which comprises contacting copper chloride particles with superheated steam and production of oxygen comprises reaction of copper oxide with dry chlorine as a part of hydrogen production by thermochemical Copper-Chlorine (Cu—Cl) cycle.

Abstract: The present invention provides isolated monoclonal antibodies, particularly human monoclonal antibodies, that specifically bind to PD-1 with high affinity. Nucleic acid molecules encoding the antibodies of the invention, expression vectors, host cells and methods for expressing the antibodies of the invention are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of the invention are also provided. The invention also provides methods for detecting PD-1, as well as methods for treating various diseases, including cancer and infectious diseases, using anti-PD-1 antibodies. The present invention further provides methods for using a combination immunotherapy, such as the combination of anti-CTLA-4 and anti-PD-1 antibodies, to treat hyperproliferative disease, such as cancer. The invention also provides methods for altering adverse events related to treatment with such antibodies individually.

Abstract: The use of luteinizing hormone receptor (LHR) as a treatment target in cancer is provided. Data demonstrates that LHR plays an important role in androgen synthesis and signaling pathways critical for prostate cancer progression. When LHR is silenced, there is a significant downregulation of androgen receptor (AR) mRNA and protein expression with a subsequent suppression of PSA expression. Data suggesting that the LH-LHR signaling cascade may be an upstream and viable therapeutic target in castration-resistant prostate cancer (CRPC) is presented.

Abstract: The present invention relates to chimieric or humanized antibodies derived from the mouse monoclonal antibody HH1. The applications of the present invention include therapeutic applications in which pharmaceutical compositions comprising the antibodies of the present invention or radioimmunoconjugates hereof are used for treating B-cell malignancies.

Abstract: The invention relates to a family of compounds that comprise fluorescent cyanine dyes. The compounds are near infrared absorbing heptamethine cyanine dyes with a 4,4-disubstituted cyclohexyl ring as part of the polymethine chromophore. The compounds are generally hydrophilic and can be chemically linked to biomolecules, such as proteins, nucleic acids, and therapeutic small molecules. The compounds can be used for imaging in a variety of medical, biological and diagnostic applications.

Abstract: Provided herein are compositions and methods for the assembly of a bioluminescent complex from two or more non-luminescent (e.g., substantially non-luminescent) peptide and/or polypeptide units. In particular, bioluminescent activity is conferred upon a non-luminescent polypeptide via structural complementation with another, complementary non-luminescent peptide.

Abstract: Derivatives of benzothiazolylbenzeneamines useful as imaging agents for nuclear imaging such as positron emission tomography of beta-amyloids are described. Methods of detecting amyloid using the compounds are described. Also disclosed is a radiolabeling method for selected compounds.

Abstract: In some aspects, compositions and methods useful for classifying tumor cells, tumor cell lines, or tumors according to predicted sensitivity to glucose restriction are provided. In some aspects, compositions and methods useful for classifying tumor cells, tumor cell lines, or tumors according to predicted sensitivity to OXPHOS inhibitors are provided. In some aspects, compositions and methods useful for classifying tumor cells, tumor cell lines, or tumors according to predicted sensitivity to biguanides are provided. In some aspects, methods of identifying subjects with cancer who are candidates for treatment with an OXPHOS inhibitor are provided. In some aspects, methods of identifying subjects with cancer who are candidates for treatment with a biguanide are provided. In some aspects, methods of treating subjects with cancers that are sensitive to glucose restriction are provided.

Abstract: Described herein is the use of a visible near infrared (VNIR) hyperspectral imaging system as a non-invasive diagnostic tool for early detection of Alzheimer's disease (AD). Also described herein is the use of a VNIR hyperspectral imaging system in high throughput screening of potential therapeutics against AD.

Abstract: A method for testing, treating, and preventing delayed food allergies includes: receiving detailed symptom, medical, and dietary histories from a patient; formulating a combination of one or more food extracts at selected concentrations for sublingual administration over a trial period; determining whether the patient's symptoms have improved, worsened, or had no change, in response to the administration of the combination; and altering the combination in response to whether the patient's symptoms have improved, worsened, or not changed, so as to induce immune system food tolerance.

Abstract: The present invention provides methods of treating LAL deficiency comprising administering to a mammal a therapeutically effective amount of lysosomal acid lipase with an effective dosage frequency. Methods of improving growth and liver function, increasing LAL tissue concentration, and increasing LAL activity in a human patient suffering from LAL deficiency are also provided.

Abstract: The development of a series of fluorescent materials including heterocycle-functionalized luminogens with aggregation-induced/enhanced emission (AIE/AEE), long wavelength emission, and high solid state fluorescence quantum efficiency is contemplated. The described fluorescent materials are promising candidates in selective luminescence-based chemosensor for Hg2+ or ATP, fluorescent staining for mitochondria in living cells with high photostability, stimuli-responsive luminescent materials, and materials for optical waveguides. In addition, these heterocycle-functionalized luminogens are particularly useful as fluorescent labels for biopolymers such as peptides, antibodies, or nucleic acids, making them useful as AIE-active biocompatible probes for clinical cancer imaging and diagnostics.

Abstract: Described herein are methods of delivering a nanoparticle to the brain of a subject by administering to the subject a nanoparticle having a nanoparticle core and a targeting agent. A variety of targeting agents may serve to promote delivery of the described nanoparticle. For example, the targeting agent may include a ligand specific for a receptor expressed by brain endothelial cells and a linker that connects the ligand to the external surface of the nanoparticle core. Additionally, the linker can promote disassociation of the ligand from the nanoparticle when inside a cell.

Abstract: Nanoparticles, such as liposomes etc., containing multiple reporter molecules, e.g. dyes, fluorophores, FRET pairs, semiconductor nanocrystals, fluorescent chelates, chelate complexes, coordination complexes, mass tags, Raman tags, lanthanides, enzymes, enzymatic substrates, etc., through a combination of multiple physical and/or chemical interactions are disclosed. The reporter molecules are associated with the nanoparticle in at least two different ways, i.e. through different mechanisms. The nanoparticle is targeted through a targeting agent such as an antibody, an antibody fragment, a nucleotide, a peptide, an aptamer, biotin, avidin, or a ligand. The nanoparticles are useful in bioassays or imaging where an analyte is to be detected by binding of the nanoparticle to the analyte and detection of a signal from the reporter molecules.

Abstract: Compositions for personal hygiene or body care, in particular deodorants, antiperspirants, massage fluids, foot care agents, shaving aids, or oral care agents, which preferably are present as a spray, including 0-7 wt % of free water, at least one cosmetic oil that is liquid under normal conditions, an oily extract from the leaves of Rumex acetosa, and in addition to the aforementioned components at least one cooling agent, wherein the amount specifications are relative to the weight of the composition without taking into account any present propellant.

Abstract: A sprayable alcohol-based sunscreen comprises an alcohol carrier, at least one sunscreen additive, and a film forming polymer comprising shellac.

Abstract: This invention relates to a solution formulation containing a tiotropium salt, 12-20% ethanol, 0.1-1.5% of water, 0.05-0.10% citric acid (or other organic acid) and an HFA propellant, wherein the percentages are percentages by weight based on the total weight of the formulation. The invention also provides a pMDI comprising a canister containing the formulation.

Abstract: A structured surfactant system with a very high degree of clarity. The system comprises water and a mixture of at least one surfactant having a HLB (Hydrophilic Lipophilic Balance) value of less than 10, and at least one surfactant having an HLB value of 10 or greater. The structured surfactant system forms multilamellar vesicles and has suspending properties without added electrolytes, carbohydrates, or polymeric thickeners. This makes the structured surfactant system particularly useful in personal care compositions.

Abstract: Described herein are oral care compositions comprising (i) a magnesium alkali metal silicate complex clay, and (ii) an orally acceptable anionic polymer, in a dentifrice base, which compositions are useful for alleviating dental sensitivity. Also provided for, are methods of making and using the compositions described herein.

Abstract: A composition comprising a solubilized magnolol analog comprising at least one magnolol analog chosen from propyl magnolol, isopropyl magnolol, butyl magnolol, and isobutyl magnolol, and PPG-1-PEG-9 lauryl glycol ether. These solubilized analogs are useful in personal care, oral care, and home care compositions to provide anti-bacterial activity and reducing the expression of pro-inflammatory mediators.

Abstract: Described herein are methods for identifying a mammal having a heightened susceptibility to enamel erosion, together with kits therefor and uses and methods related thereto.

Abstract: Compositions comprising isosorbide monoesters and alcohols comprising at least one aromatic group What are described are compositions comprising a) one or more compounds of the formula (I) in which R is a straight-chain or branched saturated alkyl group having 5 to 11 carbon atoms or a straight-chain or branched mono- or polyunsaturated alkenyl group having 5 to 11 carbon atoms, and b) one or more alcohols comprising at least one aromatic group. The compositions are distinguished in particular by an advantageous antimicrobial activity.

Abstract: The present invention provides methods of treating humans and animals with terpenes and terpenoids in order to rejuvenate the skin and increase the protective layer against irradiation by ultraviolet radiation (UVR). More specifically it provides terpenes and terpenoids as ingredients that work as persistent UVR blockers. Terpenes and terpenoid compounds support the growth of skin, skin tissue and keratinocytes and additional UVR-blocking by reason of increased stratum corneum thickness and loricrin content. Both terpenes and terpenoids may be applied topically or orally at oral or topical concentrations from about 6 mg to about 600 mg per kilogram of body weight per day effective to stimulate growth of the skin layer and prevent damage from ultraviolet radiation (UVR).

Abstract: The present invention relates to a water-in-oil emulsified skin cosmetic comprising the following ingredients (a) through (e): (a) Water: 5-50 wt % (b) Ethanol: 1-20 wt % (c) Volatile oil component: 2-50 wt % (d) Carboxy decyl trisiloxane represented by the following formula (1): 0.1-5 wt % (e) One, two or more selected from a group consisting of hydrophobized titanium dioxide, hydrophobized zinc oxide, and hydrophobized iron oxide: 2-50 wt %. The object of the present invention is to provide a water-in-oil emulsified skin cosmetic containing the aforementioned powder (e) wherein powdery squeakiness over time after application on the skin is suppressed and at the same time absorption into the skin at the time of application and the absence of stickiness after application on the skin are improved.

Abstract: The present invention relates to bioactive compositions comprising blends of camellia and feverfew serum fractions and/or kelp and parsley serum fractions.

Abstract: Provided is a compound capable of gelling various aqueous compositions containing salt, acid and the like. An amphoteric ion-type basic amino acid derivative represented by the formula (1A): wherein each substituent is as defined in DESCRIPTION, or a salt thereof.

Abstract: The present invention relates to a compound of general formula (I) in which: —R1 and R2 are simultaneously or independently H, OH, OCH3 or a C1-C5 alkyl radical, —R3 and R4 are simultaneously CH3, —or R3 is H and R4 is CH3, CH2CH3 or an isopropyl radical or a phenyl radical, —R5 is a C4-C24 alkyl radical or a 3-phenylpropanyl or 2,2-diphenylethanyl radical.

Abstract: The invention relates to a composition, especially a cosmetic composition, comprising at least one silicon resin comprising at least one T unit, at least one phenylated oil and at least one gelling agent, as well as to methods of using such compositions.

Abstract: Agents for treating keratin-containing fibers, in particular human hair, comprising a cosmetically acceptable carrier, and: (a) at least one strengthening anionic copolymer, comprising at least one structural unit of formula (I) and at least one structural unit of formula (II) and at least one structural unit of formula (III), and (b) at least one polymer comprising at least one structural unit of formula (M1), produce an excellent hold of a shape imposed on the fibers, e.g. a hairstyle. The keratin-containing fibers are given a pronounced shine and feel soft.

Abstract: The invention relates to hair care compositions comprising an effective amount of a condensation polymer having at least one, optionally quarternized or protonated, dialkylamide end-group connected through the polymer backbone to a unit derived from an alkylamide, the connection comprising at least one ester linkage.

Abstract: The present invention is directed to hydrogels and their preparation by cross-linking macromonomers by means of Diels-Alder reaction. The hydrogels described in the invention, which can gel in situ, are suitable, inter alia, as biomaterial for medical applications, as scaffolding material for living cells and as carrier system for the controlled release of drugs.

Abstract: The present invention relates to methods for providing polymeric composites with bone forming, such as with osteogenic and/or osteoinductive and/or osteoconductive, properties. The present invention further relates to polymeric composites provided by the present method and the use of thereof for bone implants, or grafts, specifically the use thereof for orbital floor reconstruction. Specifically, the present invention relates to methods for providing a composite with bone forming properties, the method comprises the steps of: a) providing a liquid, or liquefied, polymeric composition of homopolymers or copolymers of 1,3-trimethylene carbonate (TMC); b) adding to said liquid, or liquefied, polymeric composition one or more agents with osteogenic and/or osteoinductive and/or osteoconductive properties thereby providing a dispersion of said agents in said liquid or liquefied polymeric composition; and c) crosslinking the product obtained, thereby providing a composite with bone forming properties.

Abstract: The present inventions relate to a number of fields including wound healing, a waterless antibacterial disinfectant, a surgical scrub, insect repellant, and methods of treating traumatic injuries, particularly those on the battlefield where there is a need to stabilize the patient and prevent infection.

Abstract: [Problems] The objective is to provide a new low-toxic drug for external use for intractable diseases, such as erosion, decubitus, and skin ulcer, that prevents cicatrization and reduces iodine accumulation on wound surfaces with sufficiently promoting healing. [Means for solving problem] Preparation of a wound treatment drug for external use containing oily bases and iodine but substantially no white soft sugar, which is a characteristic of the drug of this invention. The invented drug prevents infection through the wound surface due to a sufficient bactericidal effect of iodine, and promotes wound healing, prevents cicatrization and reduces iodine accumulation on the wound surface by maintenance of appropriate moisture in the wound surface due to a moisturizing effect of oily bases.

Abstract: The invention provides a composition comprising: (a) about 0% to 99% by weight of at least one resin wherein the resin is selected from the group consisting of epoxy, latex, polyurethane, polyurea, polyspartic, or alkyd resins; (b) about 1%-99% by weight of tristyrenated phenol or distyrenated phenol; and (c) optionally about 2% to 98% by weight of an additional solvent.

Abstract: The present invention relates to a biodegradable polysorbitol-based osmotically active transporter (PSOAT) and gene therapy using the same as a gene carrier. The biodegradable polysorbitol-based osmotically active transporter (PSOAT) of the present invention includes a sorbitol skeleton, which imparts an osmotic pressure to the cell membrane to improve membrane permeability, thereby exhibiting remarkably improved transfection efficiency. Further, the polysorbitol-based osmotically active transporter of the present invention exhibits high DNA binding ability, effectively protects DNA from nuclease, exhibits physicochemical properties suitable for use as a gene carrier, and has very low cytotoxicity in vitro and in vivo, thereby capable of being used as a gene carrier for gene therapy.